TotalMarketCap

Design Therapeutics

DSGNNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$624.354 M

$9.75 -8.28%

Close of 6 Nov 2026

As of 6 Nov 2026, Design Therapeutics (DSGN) has a market capitalization of $624.4M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$0.00

#3616 by revenue

Earnings

-$69.8M

Loss-making

Shares outstanding

64,036,280

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #168Zevra TherapeuticsZVRA$626.6M
  2. #169Evotec SEEVO$626.1M
  3. #170Design TherapeuticsDSGN$624.4M
  4. #171Obsidian TherapeuticsOBX$620.2M
  5. #172Adlai Nortye GroupANL$619.5M

What if Design Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$440,951.19

Per share 45,226× higher

Bitcoin $1.53T

$23,859.10

Per share 2,447× higher

Apple $5.02T

$78,327.20

Per share 8,034× higher

Or at a round number

$1.00B$2.00B$5.00B$10.0B

Where these numbers come from

Share counts and financials for Design Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.